Concepedia

Carl C. Ward

CC

16

Publications

3.1K

Citations

16

H-Index

2017

Active since

Affiliations

University of California, Berkeley(Current)

Novartis (United States)

Innovative Genomics Institute

Novartis (Switzerland)

University of California, San Francisco

Carl C. Ward is an author at University of California, Berkeley specializing in medicine, drug discovery, and natural sciences.

Top concepts

MedicineBiochemistryDrug DiscoveryNatural SciencesBiomolecular EngineeringProteomicsMolecular BiologyProtein DegradationSmall MoleculesProtein Engineering

Publications per year

2017–2024

16

Publications

16

Exogenous Monounsaturated Fatty Acids Promote a Ferroptosis-Resistant Cell State

Leslie Magtanong, Pin‐Joe Ko, Milton To et al. · Cell chemical biology · 2019 · 1.1K citations · Full text

Lipid Synthesis, Biochemistry, Natural Sciences +8

Harnessing the anti-cancer natural product nimbolide for targeted protein degradation

Jessica N. Spradlin, Xirui Hu, Carl C. Ward et al. · Nature Chemical Biology · 2019 · 404 citations

Drug Targeting, Health Sciences, Biochemistry +9

Covalent Ligand Screening Uncovers a RNF4 E3 Ligase Recruiter for Targeted Protein Degradation Applications

Carl C. Ward, Jordan I. Kleinman, Scott M. Brittain et al. · ACS Chemical Biology · 2019 · 319 citations · Full text

Protein Function, Biochemistry, Biomolecular Tool +13

Deubiquitinase-targeting chimeras for targeted protein stabilization

Nathaniel J. Henning, Lydia Boike, Jessica N. Spradlin et al. · Nature Chemical Biology · 2022 · 297 citations · Full text

Deubiquitinase-targeting Chimeras, Natural Sciences, Molecular Biology +2

Improving prime editing with an endogenous small RNA-binding protein

Jun Yan, Paul Oyler, Purnima Ravisankar et al. · Nature · 2024 · 187 citations · Full text

Rows per page

1–5 of 16